Why is Torrent Pharma falling/rising?

As of 12-Aug, Torrent Pharmaceuticals Ltd. is experiencing a price increase, with its current price at Rs 3,626.70, reflecting a rise of 8.7 points or 0.24%. The stock has shown a positive performance, gaining 1.05% over the past week and 9.66% over the past month, while it is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a recent decline in investor participation, as indicated by a 61.65% drop in delivery volume, the company has demonstrated strong fundamentals, including a high return on capital employed (ROCE) of 22.33% and a low debt to EBITDA ratio of 1.26 times. Additionally, Torrent Pharma has reported positive results for the last eight consecutive quarters, contributing to its consistent returns over the past three years.
In the broader market context, Torrent Pharmaceuticals has outperformed the benchmark Sensex, which has declined by 0.59% over the past week, while the stock has gained. This trend is further supported by the stock's strong institutional holdings at 24.75%, indicating confidence from investors with substantial resources to analyze the company's fundamentals. The stock's performance is also notable as it is only 4.5% away from its 52-week high, suggesting continued investor interest despite the recent drop in trading volume. Overall, the combination of solid financial performance and relative strength against the benchmark contributes to the stock's upward movement.